Cyclacel Pharmaceuticals Inc (CYCC)
2.300
+0.51
(+28.49%)
USD |
NASDAQ |
Apr 24, 16:00
Cyclacel Pharmaceuticals Shares Outstanding: 1.318M for March 22, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
March 22, 2024 | 1.318M |
March 21, 2024 | 1.318M |
March 15, 2024 | 1.318M |
February 06, 2024 | 1.318M |
December 31, 2023 | 1.059M |
December 26, 2023 | 1.019M |
December 21, 2023 | 0.8429M |
December 18, 2023 | 0.8429M |
November 09, 2023 | 0.8429M |
November 06, 2023 | 0.8429M |
September 30, 2023 | 0.8429M |
August 09, 2023 | 0.8429M |
June 30, 2023 | 0.8429M |
May 09, 2023 | 0.8359M |
April 20, 2023 | 0.8359M |
March 31, 2023 | 0.8359M |
March 06, 2023 | 0.8359M |
December 31, 2022 | 0.8359M |
November 07, 2022 | 0.8359M |
September 30, 2022 | 0.8359M |
August 11, 2022 | 0.8359M |
August 10, 2022 | 0.8359M |
June 30, 2022 | 0.7567M |
May 09, 2022 | 0.6663M |
April 19, 2022 | 0.6662M |
Date | Value |
---|---|
March 31, 2022 | 0.6662M |
March 24, 2022 | 0.6662M |
December 31, 2021 | 0.6662M |
November 10, 2021 | 0.665M |
September 30, 2021 | 0.6532M |
August 10, 2021 | 0.6156M |
June 30, 2021 | 0.6156M |
May 12, 2021 | 0.6156M |
April 20, 2021 | 0.6156M |
March 31, 2021 | 0.6156M |
March 16, 2021 | 0.6121M |
February 24, 2021 | 0.4736M |
December 31, 2020 | 0.4165M |
December 22, 2020 | 0.3567M |
November 11, 2020 | 0.3243M |
September 30, 2020 | 0.3243M |
August 12, 2020 | 0.3243M |
June 30, 2020 | 0.3243M |
May 11, 2020 | 0.324M |
May 01, 2020 | 0.316M |
April 24, 2020 | 0.1847M |
April 15, 2020 | 0.0573M |
April 14, 2020 | 0.0573M |
March 31, 2020 | 0.0573M |
March 04, 2020 | 0.0573M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
0.0573M
Minimum
May 10 2019
1.318M
Maximum
Feb 06 2024
0.576M
Average
0.6532M
Median
Sep 30 2021
Shares Outstanding Benchmarks
Corvus Pharmaceuticals Inc | 49.04M |
Oragenics Inc | 4.481M |
Relmada Therapeutics Inc | 30.17M |
Alpine Immune Sciences Inc | 65.55M |
MAIA Biotechnology Inc | 20.58M |